Skip to Main Content

Paper Details

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.
Cancer Med
49
2018
Author NameAffiliation
Dong LinVancouver General Hospital, The University of British Columbia
Dong LinThe University of British Columbia
Dong LinBC Cancer Research Centre
Hui XueBC Cancer Research Centre
Xinpei CiVancouver General Hospital, The University of British Columbia
Xinpei CiThe University of British Columbia
Xinpei CiBC Cancer Research Centre
Robert H BellVancouver General Hospital, The University of British Columbia
Robert H BellThe University of British Columbia
Fan MoVancouver General Hospital, The University of British Columbia
Fan MoThe University of British Columbia
Neil E FleshnerPrincess Margaret Cancer Centre, University Health Network and the University of Toronto
Martin E GleaveVancouver General Hospital, The University of British Columbia
Martin E GleaveThe University of British Columbia
Colin C CollinsVancouver General Hospital, The University of British Columbia
Colin C CollinsThe University of British Columbia
Yuzhuo WangVancouver General Hospital, The University of British Columbia
Yuzhuo WangThe University of British Columbia
Yuzhuo WangBC Cancer Research Centre
  • 1 - 19

Datasets